News and Events

financial services

our commitment

our company

Parkinsons disease - loss of dopaminergic - essential tremor - Amersham HealthDetecting loss of functional dopaminergic neuron terminals in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease (PD).

Amersham has a nuclear imaging product to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinsons Disease. Access for medical professionals only.Information about Parkinsons Disease. Read more about the symptoms of Parkinsons Disease and the major factor causing Parkinsons Disease.Dopamine - Parkinsonian Syndromes are characterised by a severe loss of dopamine neurons and dopamine transporter expressed on them.In some cases Parkinsons disease causes neurogenic bladder. Other conditions which can cause neurogenic bladder include cerebrovascular disease, multiple sclerosis, motorneuron disease, spinal cord injury, spina bifida, diabetes, pelvic surgery or intervertebral disc herniation.Once the image is acquired, the appropriate thyroid imaging agent (approx. 100 MBq TcO4 or 50 MBq I-123) is injected with the patient remaining in the exactly same position.Using SPECT the dopaminergic system and the benozodiazepine receptor system are investigated. In PET not only these systems but nicotinic, muscarinic and other systems have also been evaluated.PET imaging agents - the use of radionuclides to image the cerebral blood pool, cerebral perfusion and and transmembranous transport or cerebral receptor-ligand interactions.

Americas

Visitors from the North, South and Latin American markets can find out more information about our products by using the links to their respective country below.

Europe, Asia/Pacific, Africa

For medical professionals only:

For all visitors from the European, Asian/Pacific, and African markets.

National contacts